DNA Bridges, Inc. is a leading corporate development firm that leverages seasoned scientific and business talent in the life sciences, device and pharmaceutical industries to bridge science and products.

FROM DISCOVERY TO LAUNCH our team has developed and supported the commercialization of products with combined sales over $10 billion USD. These include Herceptin, Xolair, Activase, Raptiva and Kogenate.

San Francisco Office

55 New Montgomery Street,
Suite 605
San Francisco, CA 94105

TEL 415.362.0442
FAX 415.536.2871

© Copyright 2017. All Rights Reserved.